Document is current
Any future updates will be listed below
-
Authors
Sang, Xiaopu
Xu, Junming
Wang, Yihang
Li, Jingyi
Xu, Jiasen
Chen, Xiaoni
Shi, Xianjie
Wu, Fenfang https://orcid.org/0000-0002-7136-7489
-
Funding
Funding for this research was provided by:
Shenzhen Science and Technology Program (JCYJ20220818103407016)
Shenzhen Medical Research Fund (SMRF.D2301015)
National Natural Science Foundation of China (82172107)
Guangdong Basic and Applied Basic Research Foundation (2024A1515011222)
Special Funds for Strategic Emerging Industry of Shenzhen (F-2022-Z99-502266)
- License Information
-
More Information
Article History
Received: 30 August 2024
Accepted: 18 December 2024
First Online: 24 December 2024
Declarations
:
: This study does not involve human participants or animals. Use of human pluripotent cell lines (UC and H1) was approved by the ethics committee of Shenzhen Hospital, Beijing University of Chinese Medicine in March 2021 (SZLDH2021LSYA-010).
: Not applicable.
: The authors declare that they have not use AI-generated work in this manuscript.
: The authors have declared no competing interests.
